Tissue	B:C4048299
factor	I:C4048299
-	O
dependent	O
coagulation	O
activation	I:C2244461
by	O
heme	O
:	O
A	O
thromboelastometry	O
study	I:C3661505
Heme	O
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	O
.	O

Tissue	O
factor	I:C4048299
-	O
dependent	O
coagulation	B:C2244461
activation	I:C2244461
by	O
heme	O
:	O
A	O
thromboelastometry	O
study	I:C3661505
Heme	O
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	O
.	O

Tissue	O
factor	I:C4048299
-	O
dependent	O
coagulation	O
activation	I:C2244461
by	O
heme	B:C0018966
:	O
A	O
thromboelastometry	O
study	I:C3661505
Heme	O
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	O
.	O

Tissue	O
factor	I:C4048299
-	O
dependent	O
coagulation	O
activation	I:C2244461
by	O
heme	O
:	O
A	O
thromboelastometry	B:C3661505
study	I:C3661505
Heme	O
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	O
.	O

Tissue	O
factor	I:C4048299
-	O
dependent	O
coagulation	O
activation	I:C2244461
by	O
heme	O
:	O
A	O
thromboelastometry	O
study	I:C3661505
Heme	B:C0018966
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	O
.	O

Tissue	O
factor	I:C4048299
-	O
dependent	O
coagulation	O
activation	I:C2244461
by	O
heme	O
:	O
A	O
thromboelastometry	O
study	I:C3661505
Heme	O
has	O
been	O
characterized	O
as	O
potent	O
trigger	O
of	O
inflammation	B:C0021368
.	O

In	O
hemostasis	B:C0019116
,	O
although	O
heme	O
has	O
been	O
shown	O
to	O
both	O
induce	O
and	O
inhibit	O
different	O
compartments	O
of	O
hemostasis	O
,	O
its	O
net	O
effect	O
on	O
the	O
hemostatic	O
balance	O
,	O
and	O
the	O
biological	O
relevance	O
of	O
these	O
effects	O
remain	O
to	O
be	O
determined	O
.	O

In	O
hemostasis	O
,	O
although	O
heme	B:C0018966
has	O
been	O
shown	O
to	O
both	O
induce	O
and	O
inhibit	O
different	O
compartments	O
of	O
hemostasis	O
,	O
its	O
net	O
effect	O
on	O
the	O
hemostatic	O
balance	O
,	O
and	O
the	O
biological	O
relevance	O
of	O
these	O
effects	O
remain	O
to	O
be	O
determined	O
.	O

In	O
hemostasis	O
,	O
although	O
heme	O
has	O
been	O
shown	O
to	O
both	O
induce	O
and	O
inhibit	O
different	O
compartments	O
of	O
hemostasis	B:C0019116
,	O
its	O
net	O
effect	O
on	O
the	O
hemostatic	O
balance	O
,	O
and	O
the	O
biological	O
relevance	O
of	O
these	O
effects	O
remain	O
to	O
be	O
determined	O
.	O

In	O
hemostasis	O
,	O
although	O
heme	O
has	O
been	O
shown	O
to	O
both	O
induce	O
and	O
inhibit	O
different	O
compartments	O
of	O
hemostasis	O
,	O
its	O
net	O
effect	O
on	O
the	O
hemostatic	B:C0019116
balance	O
,	O
and	O
the	O
biological	O
relevance	O
of	O
these	O
effects	O
remain	O
to	O
be	O
determined	O
.	O

In	O
hemostasis	O
,	O
although	O
heme	O
has	O
been	O
shown	O
to	O
both	O
induce	O
and	O
inhibit	O
different	O
compartments	O
of	O
hemostasis	O
,	O
its	O
net	O
effect	O
on	O
the	O
hemostatic	O
balance	B:C0019868
,	O
and	O
the	O
biological	O
relevance	O
of	O
these	O
effects	O
remain	O
to	O
be	O
determined	O
.	O

Herein	O
we	O
evaluated	O
the	O
effect	O
of	O
heme	B:C0018966
on	O
hemostasis	O
using	O
a	O
global	O
assay	I:C0005507
able	O
to	O
generate	O
clinically	O
relevant	O
data	O
in	O
several	O
other	O
complex	O
hemostatic	O
diseases	I:C0600502
.	O

Herein	O
we	O
evaluated	O
the	O
effect	O
of	O
heme	O
on	O
hemostasis	B:C0019116
using	O
a	O
global	O
assay	I:C0005507
able	O
to	O
generate	O
clinically	O
relevant	O
data	O
in	O
several	O
other	O
complex	O
hemostatic	O
diseases	I:C0600502
.	O

Herein	O
we	O
evaluated	O
the	O
effect	O
of	O
heme	O
on	O
hemostasis	O
using	O
a	O
global	B:C0005507
assay	I:C0005507
able	O
to	O
generate	O
clinically	O
relevant	O
data	O
in	O
several	O
other	O
complex	O
hemostatic	O
diseases	I:C0600502
.	O

Herein	O
we	O
evaluated	O
the	O
effect	O
of	O
heme	O
on	O
hemostasis	O
using	O
a	O
global	O
assay	I:C0005507
able	O
to	O
generate	O
clinically	O
relevant	O
data	O
in	O
several	O
other	O
complex	O
hemostatic	B:C0600502
diseases	I:C0600502
.	O

Citrated	O
whole	B:C0444256
blood	I:C0444256
samples	I:C0444256
from	O
healthy	O
participants	I:C1708335
were	O
stimulated	O
by	O
heme	O
or	O
vehicle	O
and	O
incubated	O
for	O
4h	O
at	O
37째C	O
.	O

Citrated	O
whole	O
blood	I:C0444256
samples	I:C0444256
from	O
healthy	B:C1708335
participants	I:C1708335
were	O
stimulated	O
by	O
heme	O
or	O
vehicle	O
and	O
incubated	O
for	O
4h	O
at	O
37째C	O
.	O

Citrated	O
whole	O
blood	I:C0444256
samples	I:C0444256
from	O
healthy	O
participants	I:C1708335
were	O
stimulated	O
by	O
heme	B:C0018966
or	O
vehicle	O
and	O
incubated	O
for	O
4h	O
at	O
37째C	O
.	O

Citrated	O
whole	O
blood	I:C0444256
samples	I:C0444256
from	O
healthy	O
participants	I:C1708335
were	O
stimulated	O
by	O
heme	O
or	O
vehicle	O
and	O
incubated	B:C1439852
for	O
4h	O
at	O
37째C	O
.	O

Rotational	B:C3661505
thromboelastometry	I:C3661505
was	O
immediately	O
performed	O
.	O

The	O
participation	O
of	O
tissue	B:C4048299
factor	I:C4048299
in	O
coagulation	O
activation	I:C2244461
was	O
evaluated	O
using	O
inhibitory	O
antibody	O
.	O

The	O
participation	O
of	O
tissue	O
factor	I:C4048299
in	O
coagulation	B:C2244461
activation	I:C2244461
was	O
evaluated	O
using	O
inhibitory	O
antibody	O
.	O

The	O
participation	O
of	O
tissue	O
factor	I:C4048299
in	O
coagulation	O
activation	I:C2244461
was	O
evaluated	O
using	O
inhibitory	O
antibody	B:C0003241
.	O

Heme	B:C0018966
was	O
able	O
of	O
inducing	O
ex	O
vivo	O
coagulation	O
activation	O
in	O
whole	O
blood	I:C0370231
,	O
affecting	O
predominantly	O
parameters	O
associated	O
with	O
the	O
initial	O
phases	O
of	O
clot	O
formation	I:C3156338
.	O

Heme	O
was	O
able	O
of	O
inducing	O
ex	O
vivo	O
coagulation	B:C0005778
activation	O
in	O
whole	O
blood	I:C0370231
,	O
affecting	O
predominantly	O
parameters	O
associated	O
with	O
the	O
initial	O
phases	O
of	O
clot	O
formation	I:C3156338
.	O

Heme	O
was	O
able	O
of	O
inducing	O
ex	O
vivo	O
coagulation	O
activation	O
in	O
whole	B:C0370231
blood	I:C0370231
,	O
affecting	O
predominantly	O
parameters	O
associated	O
with	O
the	O
initial	O
phases	O
of	O
clot	O
formation	I:C3156338
.	O

Heme	O
was	O
able	O
of	O
inducing	O
ex	O
vivo	O
coagulation	O
activation	O
in	O
whole	O
blood	I:C0370231
,	O
affecting	O
predominantly	O
parameters	O
associated	O
with	O
the	O
initial	O
phases	O
of	O
clot	B:C3156338
formation	I:C3156338
.	O

This	O
activation	O
effect	O
was	O
at	O
least	O
partially	O
dependent	O
on	O
hematopoietic	O
tissue	B:C4048299
factor	I:C4048299
,	O
since	O
the	O
effects	O
of	O
heme	O
were	O
partially	O
abrogated	O
by	O
the	O
inhibition	O
of	O
human	O
tissue	O
factor	I:C4048299
.	O

This	O
activation	O
effect	O
was	O
at	O
least	O
partially	O
dependent	O
on	O
hematopoietic	O
tissue	O
factor	I:C4048299
,	O
since	O
the	O
effects	O
of	O
heme	B:C0018966
were	O
partially	O
abrogated	O
by	O
the	O
inhibition	O
of	O
human	O
tissue	O
factor	I:C4048299
.	O

This	O
activation	O
effect	O
was	O
at	O
least	O
partially	O
dependent	O
on	O
hematopoietic	O
tissue	O
factor	I:C4048299
,	O
since	O
the	O
effects	O
of	O
heme	O
were	O
partially	O
abrogated	O
by	O
the	O
inhibition	O
of	O
human	B:C0086418
tissue	O
factor	I:C4048299
.	O

This	O
activation	O
effect	O
was	O
at	O
least	O
partially	O
dependent	O
on	O
hematopoietic	O
tissue	O
factor	I:C4048299
,	O
since	O
the	O
effects	O
of	O
heme	O
were	O
partially	O
abrogated	O
by	O
the	O
inhibition	O
of	O
human	O
tissue	B:C4048299
factor	I:C4048299
.	O

In	O
conclusion	O
,	O
using	O
a	O
global	O
hemostasis	B:C0019116
assay	O
,	O
our	O
study	O
confirmed	O
that	O
heme	O
is	O
able	O
to	O
activate	O
coagulation	I:C2244461
in	I:C2244461
whole	I:C2244461
blood	I:C2244461
,	O
in	O
a	O
tissue	O
factor	I:C4048299
-	O
dependent	O
way	O
.	O

In	O
conclusion	O
,	O
using	O
a	O
global	O
hemostasis	O
assay	O
,	O
our	O
study	O
confirmed	O
that	O
heme	B:C0018966
is	O
able	O
to	O
activate	O
coagulation	I:C2244461
in	I:C2244461
whole	I:C2244461
blood	I:C2244461
,	O
in	O
a	O
tissue	O
factor	I:C4048299
-	O
dependent	O
way	O
.	O

In	O
conclusion	O
,	O
using	O
a	O
global	O
hemostasis	O
assay	O
,	O
our	O
study	O
confirmed	O
that	O
heme	O
is	O
able	O
to	O
activate	B:C2244461
coagulation	I:C2244461
in	I:C2244461
whole	I:C2244461
blood	I:C2244461
,	O
in	O
a	O
tissue	O
factor	I:C4048299
-	O
dependent	O
way	O
.	O

In	O
conclusion	O
,	O
using	O
a	O
global	O
hemostasis	O
assay	O
,	O
our	O
study	O
confirmed	O
that	O
heme	O
is	O
able	O
to	O
activate	O
coagulation	I:C2244461
in	I:C2244461
whole	I:C2244461
blood	I:C2244461
,	O
in	O
a	O
tissue	B:C4048299
factor	I:C4048299
-	O
dependent	O
way	O
.	O

These	O
findings	O
could	O
explain	O
the	O
disturbance	O
in	O
hemostatic	B:C0019116
balance	O
observed	O
in	O
conditions	O
associated	O
with	O
the	O
release	O
of	O
heme	O
such	O
as	O
sickle	O
cell	I:C0002895
disease	I:C0002895
.	O

These	O
findings	O
could	O
explain	O
the	O
disturbance	O
in	O
hemostatic	O
balance	B:C0019868
observed	O
in	O
conditions	O
associated	O
with	O
the	O
release	O
of	O
heme	O
such	O
as	O
sickle	O
cell	I:C0002895
disease	I:C0002895
.	O

These	O
findings	O
could	O
explain	O
the	O
disturbance	O
in	O
hemostatic	O
balance	O
observed	O
in	O
conditions	O
associated	O
with	O
the	O
release	O
of	O
heme	B:C0018966
such	O
as	O
sickle	O
cell	I:C0002895
disease	I:C0002895
.	O

These	O
findings	O
could	O
explain	O
the	O
disturbance	O
in	O
hemostatic	O
balance	O
observed	O
in	O
conditions	O
associated	O
with	O
the	O
release	O
of	O
heme	O
such	O
as	O
sickle	B:C0002895
cell	I:C0002895
disease	I:C0002895
.	O

